Delivery Order SPE2DB20D3505-SPE2DB25FT9Z6

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $20,808.22 and is for the delivery of Losartan-HCTZ 100-12.5 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 6, 2024. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Losartan-HCTZ 100-12.5 mg tablets. The contract has a firm fixed price of $30,541.60 and a period of performance through July 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to provide a comprehensive range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,596.20, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,076.52 firm fixed-price contract is for the delivery of 4,566,043,778 units of the prescription drug Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of October 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,333.47, is for the delivery of losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has a firm fixed price pricing type and an ultimate completion date of October 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,064.20, is for the delivery of 4564590417 Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of May 14, 2024 and is a firm fixed-price contract. This award is not associated with a set-aside program. AmerisourceBergen holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Losartan-HCTZ 100-25 mg tablets, a cardiovascular medication, and has a ceiling value of $17,188.97. The contract is a firm fixed-price delivery order with a completion date of November 26, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $2,202.93 and covers the delivery of Losartan-HCTZ 100-12.5 mg tablets over a period ending on December 21, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of August 1, 2024 and a ceiling value of $36,216.38. The contract is not associated with any set-aside program. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies to...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of losartan-HCTZ 100-12.5 mg tablets. The contract has a ceiling value of $7,409.12 and a period of performance through September 10, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide these prescription medications to support military treatment facilities and...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT9Z6
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,153.53, is for the supply of Losartan-HCTZ 100-25 mg tablets. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is not designated as a set-aside.

Generated 5/22/25, 8:24 PM